ImmuCell Corporation (ICCC)
Market Closed
10 Aug, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
10. 97
-0.03
-0.2727%
$
99.51M Market Cap
- P/E Ratio
- Div Yield
11,852 Volume
0 Eps
$ 11
Previous Close Investors:
Want to track ICCC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ImmuCell Corporation (ICCC) Statistics
Valuation metrics
Market Cap 99.51M
Enterprise value 105.48M
Trailing P/E (ttm) -183.95
Forward P/E -
PEG ratio 0.37
Price/Sales (ttm) 3.32
Price/Book (mrq) 3.42
Enterprise Value/Revenue 3.52
Enterprise Value/EBITDA 44.2
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 19.93K
Average volume (90 days) 34.36K
Price summary
52-Week low 4.52
52-Week high 12.1
Beta -
50-Day moving average 10.85
200-Day moving average 7.5
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:100
Last split Date 25 Jul 1990
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.02%
Operating margin 0.08%
Operational effectiveness
Return on assets -0.01%
Return on equity -0.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.31
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.06
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.75
Total debt (mrq) -
Total Debt/Equity (mrq) 0.44
Current ratio (mrq) 4.82%
Book value per share (mrq) 3.22
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
